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Clinical outcomes from The BodyMind Approach™  
in the treatment of patients with medically unexplained symptoms  
in primary health care in England: practice-based evidence 
Abstract 
This article builds on Payne (2015) and reports on practice–based evidence arising out of 
the delivery of a new and innovative service using The BodyMind Approach™ (TBMA) for 
the treatment of patients with medically unexplained symptoms (MUS) in primary care in the 
National Health Service (NHS) in Hertfordshire, a county near London, England, in the UK. 
The analysis of data collected for three groups (N=16) over 18 months used standardised 
assessment tools and other relevant information at pre, post and at a six month follow up. 
The outcomes for patients in this small scale piece of practice based evidence indicated that 
there were reductions in symptom distress, anxiety and depression, increased overall 
wellbeing and improvement in activity levels. Patients developed self-management of their 
symptoms through understanding, acceptance and coping strategies. The increased 
knowledge, exchange of experiences together with understanding and acceptance from 
others promoted a sense of wellbeing. Thus, the programme was experienced to be a 
beneficial intervention. In addition to the clinical outcomes reported here there are other 
benefits for NHS England for example, savings on medication and referral costs and General 
Practitioner (GP) capacity enhanced. The clinical service is based on previous research 
conducted by Payne and Stott (2010). This article focusses solely on the analysis and 
interpretation of clinical outcomes from the practice-based evidence.  
Keywords: The BodyMind Approach™; medically unexplained symptoms; primary care; 
practice-based evidence 
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Introduction 
The innovative clinical service reported in this article is being offered to primary care patients 
with medically unexplained symptoms (MUS) through the National Health Service (NHS) in a 
county in England. Edwards, Stern, Clarke, Ivbijaro, and Kasney (2010) define MUS as ‘a 
clinical and social predicament, includes broad spectrum of presentations, difficulty 
accounting for symptoms based on known pathology’ (ibid p 1). They go on to say in 
Diagnostic and Statistical Manual for Mental Disorders (DSM IV-TR) that the nomenclature 
for MUS has several categories including somatisation disorder, conversion disorder, pain 
disorder, and that the criteria is cumbersome and unhelpful in practice. 
Both the DSM-5 and the proposed International Classification of Diseases–11th Revision 
(ICD-11) change the criteria for MUS and replace the term by Somatic Symptom and 
Related Disorders (SSD). In DSM-5 F45.1 SSD is cross-walked to ICD9 code 300.82 
(ICD10-CM F45.1). SSD is defined in DSM-5 as symptoms that are distressing or result in 
significant disruption to feeling, thoughts and behaviour, related to somatic symptoms as 
manifested by at least one of the following: disproportionate and persistent thoughts about 
the seriousness of one’s symptoms, or persistently high levels of anxiety about health 
symptoms and excessive time and energy devoted to these symptoms of health concerns 
(Diagnostic and Statistical Manual of Mental Disorders-5, 2013).  It states that Somatic 
Symptom and Related Disorders includes the diagnoses of somatic symptom disorder, 
illness anxiety disorder, conversion disorder (functional neurological symptom disorder), 
psychological factors affecting other medical conditions, factitious disorder other specified 
somatic symptom and related disorder, and unspecified somatic symptom and related 
disorder. All of the disorders share a common feature: the prominence of somatic symptoms 
associated with significant distress and impairment. Such patients are commonly found in 
primary care and less encountered in mental health settings. The term is thought to be more 
useful than that of MUS in primary care (Creed, Guthrie, Fink, Henningsen, Rief, 2010). 
SSD includes the former somatisation disorder, undifferentiated somatoform disorder, and 
pain disorder. The change is that the diagnostic criteria are no longer based on the presence 
of MUS, but focuses on one or more somatic symptoms that are distressing and/or result in 
significant disruption of everyday life. Although there are criticisms (Voigt, Wollburg, 
Weinmann, Herzog, Meyer, 2012; Frances, 2013) this change removes the diagnostic 
problem of having to distinguish between medically explained and unexplained symptoms 
(Creed, et al 2010).  The shortcomings of the MUS category is the mind-body dualism 
present in the unreliable classification of complaints as medically explained or not (Creed 
2009; Sharpe, Mayou & Walker, 2006) and the random categorisation into different 
somatoform disorders (Leiknes, Finset, Moum & Sandanger, 2006).  
This dualism reinforces the GP training to address physical rather than mental health issues 
and the patient’s perception that their symptom is purely physical because of the sensory 
experience.   It reinforces dualistic thinking and the idea that illness is either biological or 
psychological. The term defines the illness by what it is not: i.e. it implies no organic cause 
which is not necessarily accurate and limits treatment. Research has shown that most 
patients prefer a positive description of symptoms i.e. an explanation of what it is rather than 
what it is not. The term MUS may seem glib communicating that nothing can be done. 
Cognitive Behaviour Therapy (CBT) with relaxation and/or graded exercise has some 
effectiveness for some symptoms (Whiting, Bagnall, Sowden, Cornell, Mulrow, 2001). 
Although psychological treatment may work in some cases this does not reflect that the 
symptoms are necessarily psychological (Creed, Henningsen & Fink, 2011). Other terms in 
use in a Department of Health (DH) recent document on MUS (DH 2014) are claimed to be 
more acceptable to patients such as persistent physical symptoms or functional 
syndromes/symptoms (FS) (Stone, Stone, Wojcik, Durrance, Carson, 2002). The term 
“functional” here is used because it is assumed that the disorder is one of function, which 
may be physical and/or psychosocial function, rather than anatomical structure (Sharpe, 
2000). 
The clinical outcomes of TBMA as a treatment reported here are based upon the definition 
and criteria for MUS used in DSMIV i.e. before the changes made with reference to MUS in 
DSM-5. 
The ® treatment service is delivered in the English NHS primary care setting by a University 
of Hertfordshire spin-out company Pathways2Wellbeing (P2W)™. Primary care in the NHS 
refers to the first port of call for patients in the community which involves GPs working in 
local practices. Secondary care involves hospitals and other medical establishments or 
treatments to which GPs refer patients. GPs act as the access, by way of referral, to any 
specialist interventions in either primary or secondary care. The treatment service offered by 
P2W is called Symptoms Groups to patients and The MUS Clinic to the GPs referring 
patients with various medically unexplained symptoms (such as fibromyalgia, IBS, chronic 
pain or chronic fatigue) from primary care.  At no time is the term MUS used with patients. 
The groups use TBMA, which is based on a bio-psychosocial model derived from aspects of 
interpersonal therapy, embodied group psychotherapy (dance movement 
psychotherapy/authentic movement), the arts and mindfulness. It is not designed as a form 
of psychotherapy, but an adaptation for non-psychologically minded patients deriving from 
an integration of the above. The groups are called workshops and the treatment is a course. 
This approach has been hitherto researched and delivered as a service in the NHS with 
patients with medically unexplained symptoms (MUS) (previously termed psychosomatic 
conditions). These patients have very limited pathways for supporting their wellbeing in 
primary care and are high health utilizers (Bermingham, Cohen, Hague, Parsonage, 2010). 
They suffer with chronic, physical symptoms or conditions which do not appear to have an 
organic, medical diagnosis and normally with co-occurring anxiety and/or depression.  The 
negative impact of the conditions and lack of curative treatments means effective non-
pharmacological interventions that promote better coping abilities need to be developed. 
TBMA treatment aims to bridge the gap between mental and physical health services for 
these patients with chronic MUS. It uses the inter-relationship between body and mind for 
the treatment of such patients with these persistent symptoms. Further details on the 
approach can be found in Payne (2013b) and Lin and Payne (2014). The University’s newly 
endorsed company P2W is the vehicle for the service with the knowledge arising from the 
pilot research being transferred into a real world service delivery as clinical progress 
reporting. This recent service delivery project (2012-2013) was funded by the DH initiative 
Quality, Innovation, Productivity and Prevention (QIPP) scheme in a competitive bid from the 
authors and Hertfordshire Primary Care Trust (Mental Health). The delivery took place in 
community settings with patients referred by GPs from primary care. The service was free at 
the point of delivery. The naturalistic delivery and the lessons learned from the experience 
are documented in Payne (2014). This article focusses solely on an evaluation of the clinical 
outcomes for the patients from a small scale implementation of TBMA in the NHS. The small 
sample size (N=16) and the lack of a control arm means that the outcomes cannot be 
generalised with any confidence. However, the indicative outcomes which are very positive 
are consistent with a previous pilot study conducted at the University of Hertfordshire (Payne 
& Stott 2010) and may be transferable. 
Medically unexplained symptoms 
Patients with chronic MUS (presenting for over six months with the same symptom/s) are 
quite complex and are high health utilizers for whom there are few pathways for support and 
self-management other than (for a few symptoms) CBT and/or pain relief.  In a recent 
practice guideline published by the UK DH, (July 2014) as a part of Improving Access to 
Psychological Therapies (IAPT) initiative, it is concluded that “community mental health 
teams and primary care mental health services have not been successful in engaging with 
patients experiencing MUS, as patients often do not perceive their condition to be related to 
mental health problems, and attempting to engage them in traditional mental health 
approaches is often ineffective” (DH, 2014 p 5). 
Therefore to review the research on self-management in CBT is not relevant to the purpose 
of this article. 
A systematic review of research (Du, Yuan, Xiao, Chu, Qiu, 2011) was conducted for the 
self-management programmes on pain and disability for chronic musculoskeletal pain 
conditions (not necessarily MUS). For chronic back pain, there was insufficient evidence to 
determine the effectiveness of self-management programmes. In a more recent review 
(Oliveira, Ferreira, Maher, Pinto, Refshauge, 2012) for non-specific low back pain results 
showed moderate-quality evidence that self-management has small effects on pain and 
disability which challenge the endorsement of self-management in treatment guidelines. 
MUS patients are high utilisers of health care resources. In 2008-9 approximately £3 billion 
was spent on patients with MUS in the NHS (11% of total budget) rising to £18 billion 
including the cost to the wider economy through lost productivity (Bermingham et al, 2010). 
No serious medical cause was the diagnosis in 25% - 50% of all primary care visits (Barsky 
& Borus, 1995) and only 10% - 15% of the 14 common, physical symptoms seen in half of 
GP consultations over 12 months were found to be caused by an organic illness (Morriss, 
Dowrick, Salmon, 2007), resulting in 85-90% being of unknown biological aetiology. These 
patients are often taking medication, regularly visit health professionals (more than five times 
per year) and for longer consultations than the 11 minutes per visit per symptom allowable in 
the NHS. Furthermore, they use many resources accounting for as many as one in five new 
consultations (Bridges & Goldberg, 1985). They frequently have high cost referrals to 
secondary care for tests and scans and usually present with anxiety and/or depression, 
which is understandable (Simon, VonKorff, Piccinelli, Fullerton, Ormel, 1999; Aguara, 2010).  
Dimsdale, Sharma and Sharpe (2011) showed that although MUS/somatoform disorders are 
common, for those health professionals seeing such patients there is considerable confusion 
regarding the diagnostic terminology and a reluctance to use these diagnostic labels.  For 
example, GPs rarely use the terms MUS or somatoform disorder to their patients, instead 
diagnosing fibromyalgia, ME, IBS, chronic fatigue etc. Neither do GPs routinely use the ICD-
10 subcategories of various somatoform disorders. Consequently, in the experience of the 
authors the specific number of this huge population in each GP practice is hidden from the 
GP practice data base. However, GPs can identify those known as heart-sink, frequent flyer 
and fat file patients whom they refer to the MUS Clinic. As a result of a systemic lack of 
classification many patients who have MUS/somatoform disorder are not able to be identified 
to receive the support of the MUS Clinic. 
Grover, Aneja, Sharma, Malhotra and Varma (2014) found no significant differences 
between the various subcategories of somatoform disorders with regard to the prevalence of 
somatic symptoms (including somatoform pain disorder), anxiety or depression and 
psychological correlates of alexithymia, hypochondriasis and somato-sensory amplification. 
Their findings also supported the co-occurrence of anxiety and depression in two thirds of 
this population. Anxiety disorder (formally hypochondriasis) or functional neurological 
disorder (formally conversion) may also be diagnosed. 
Khan, Khan A and Harezlak (2003) call for better management strategies to be developed in 
primary care for prevalent, medically unexplained, persistent somatic symptoms which are a 
health care priority and a long term condition. Currently patients either attend physical or 
mental health services and the treatment is separately delivered as medication/pain 
management or psychological therapies respectively. This system is unhelpful to the patient 
since it splits off mental from physical health aspects. In England, CBT for three conditions: 
IBS; chronic fatigue and fibromyalgia, has been found to help mental health in the short term 
and encouraged through a government initiative called Improving Access to Psychological 
Therapies (IAPT) which also targets people with long-term conditions in which MUS can be 
categorised. However, only a third of MUS patients with varied symptoms attend this 
treatment (Hague, 2008), probably due to their physical explanation for their symptoms and 
the stigma attached to mental health services. Thus it seems CBT is unacceptable to this 
patient population, they require an accessible and integrated approach which acknowledges 
their bodily based physical experience whilst exploring this at emotional and cognitive levels. 
 
The Research on which TBMA is founded 
A pilot study into the TBMA intervention took place near London, England in 2005-20071 
(Payne, 2009; Payne & Stott, 2010; Payne, 2010). From these earlier research studies, 
specifically the proof of concept pilot study (Payne & Stott 2010), patient benefits from TBMA 
intervention were improved wellbeing and activity levels; decreased 
symptom/anxiety/depression levels; improved self-management of symptoms; and lower or 
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stabilized medication levels. For GPs the benefits included reduced attendance at GPs 
and/or hospitals and reduced costs of medication. 
Furthermore, a previous health economic analysis of TBMA compared with CBT showed that 
the cost savings would be large in primary care but that secondary care they would be even 
greater (Payne & Fordham, 2008) the findings of which are supported by a report from the 
DH (2012). Thus this evidence makes TBMA courses attractive for the NHS due to the 
current austerity situation in England. 
Following extensive consultation with primary care GPs in a market research study by 
Payne, Eskioglou and Story (2009), funded by the East of England Development Agency, a 
need was identified by the GPs for a pathway for the treatment and support of this patient 
population, for most of whom they thought CBT/psychological therapies was inaccessible 
and/or inappropriate. In support of the lack of accessibility for patients of psychological 
therapies and/or referrals from GPs psychologists in IAPT complained that they were not 
getting enough referrals from GPs. When TBMA was described to these GPs in a focus 
group (and later in the QIPP project) as a possible pathway it was welcomed enthusiastically 
as being more acceptable and providing choice for patients.  
The pilot study led to the development of a manual for the delivery of TBMA by experienced 
and qualified Masters level dance movement psychotherapists trained in TBMA by 
pathways2wellbeing. This manual is not a recipe for sessions but rather offers nudges for 
the planning, specific themes which need to be covered and when and for the conducting of 
group sessions. The mind-set/attitude of the facilitator is described as the most important 
ingredient for promoting change. The facilitator is encouraged to be mindful, sensitive, 
adapting practices to each group’s needs, ensuring interventions, aims and outcomes are 
explained clearly to patients and addressing needs as they arise rather than being 
prescriptive. The manual content gives examples of sessions and case studies, emphasising 
the facilitator’s competencies expected. The manual was further refined as the QIPP service 
delivery was conducted in an evaluation by the facilitators during the delivery, and no doubt 
it will be honed still further with each new delivery of the groups by more facilitators.  
As well as the manual being continuously updated TBMA is being evaluated as an on-going 
process during delivery of the service. Manuals developed for conducting psychological 
therapies in research studies are not widely distributed and their contents do not appear to 
have been evaluated (Payne, Westland, Karkou & Warneke, 2014). Research findings 
based on the application of treatment manuals have led to the endorsement of psychological 
treatments based on the use of brand names e.g. Body Orientated Psychotherapy, CBT or 
Interpersonal Therapy. Endorsing brand-named treatments assumes they are practised in a 
manner consistent with the research treatment manuals but without evidence to support this 
assertion. In this service delivery treatment integrity has been ensured by a triangulation (a 
three-way comparative analysis) between what patients have said about their experience of 
the approach what the facilitator says she did in the pilot study (Payne 2009), and the 
manual which will continue to be evaluated by the facilitators and by expert opinion 
evaluators external to the delivery. 
 
The BodyMind Approach™  
There are many different definitions of psychotherapy, for example ‘The treatment of 
disorders of the mind or personality by psychological methods’ (Oxford English Dictionary 
2015) or ‘the informed and intentional application of clinical methods and interpersonal 
stances derived from established psychological principles for the purpose of assisting people 
to modify their behaviours, cognitions, emotions, and/or other personal characteristics in 
directions that the participants deem desirable’ (Campbell, Norcross, Vasquez, Kaslow; 
2013, p 98). It is normally the response to specific or non-specific signs of clinically 
diagnosable and/or existential crises, often dubbed talking therapy aiming to help clients to 
fulfil their potential or cope better with the emotional problems of life. 
Whilst TBMA is not psychotherapy in the narrow definition of the term it has its roots in a 
psychotherapy school of thought. It works not only with the mind, emotions and cognition but 
also with the physical symptoms, it is a bio-psychosocial model. 
TBMA can be seen as one solution to the problem of patients with MUS. It has been 
designed specifically to be accessible to this patient population and to provide choice. It aims 
towards integrating body and mind, starting with the bodily symptom and its sensory 
experience to promote self-management and wellbeing in people with chronic MUS. It 
employs somatic mindfulness (or bodymindfulness) - movement, a moment-to-moment 
awareness of the body in motion or stillness, from the discipline of Authentic Movement 
(Whitehouse, 1999; Chodorow, 1992; Adler, 2002; Payne, 2006a) which is sometimes 
employed in dance movement psychotherapy. Authentic movement is where the mover 
moves spontaneously with eyes closed/downwardly focussed in the presence of a witness. 
In TBMA authentic movement is coupled with mindfulness practices, adapted to be 
accessible to people with persistent symptoms employing simple practices scaffolding them 
into elements of the final form. There is no pressure to engage with anything with which 
patients might be uncomfortable. The facilitator always offers alternatives and choices.  
Kabat-Zinn (1982; 1985; 1986) pioneered the development of mindfulness meditation with 
patients with chronic pain and a mindfulness stress reduction programme for psoriasis 
(Kabat-Zinn, 1998) as well as applying it to patients with anxiety (Kabat-Zinn, 1995).  Since 
then there has been a prolific study of mindfulness. It has been shown to reduce depression 
as well as anxiety.  Hofmann, Sawyer, Witt and Oh (2010) conducted a meta-analysis of 39 
studies that explored the use of mindfulness-based stress reduction. The researchers 
concluded that mindfulness-based therapy may be useful in altering affective and self-
regulatory processes that underlie multiple clinical issues particularly anxiety and/or 
depression.  Others have supported these findings, for example, Vollested, Nielson and 
Nielson (2012); Roemer, Lee, Salters-Pedneault, Erisman, and Orsillo (2009) and an earlier 
study by Grossman, Nieman, Schmidt and Walach (2004). A systematic review conducted 
by Sharma and Rush (2014) found that out of 17 studies combining mindfulness meditation 
and yoga 16 demonstrated positive changes in psychological or physiological outcomes 
related to anxiety and/or stress. Williams (2008) reviewed four studies showing a correlation 
between measures of mindfulness as a trait and cognitive features of depressive 
vulnerability, specifically decreased rumination, avoidance of internal experiences and an 
increase in the relinquishment of negative thoughts and unattainable goals. Other studies 
demonstrate that a mindful or experiential mode of self-attention in depressed subjects is 
relatively more conducive to both improved memory for autobiographical events (Watkins & 
Teasdale, 2004) and improved problem solving ability (Watkins & Moulds, 2005).  
Nevertheless none of these approaches address the lived bodily felt sensory experience 
from a phenomenological perspective or address the importance of body awareness as a 
vehicle for change. The subjective experiencing body (Gallagher & Zahavi, 2007), whether 
engaging with the world’s affordances (Gibson, 1979) through the tactile sense, movement 
or in stillness, is the fundamental basis for all feelings, sensations, perceptions or object 
manipulation which in turn actively underlies cognition and meaning-making (Merleau-Ponty, 
1962 & 1965; Dewey, 1991). There is thus an integration of physical and mental aspects, 
perception and action, doing and being. TBMA builds on this notion of the body functioning 
as a dynamic constituent of the mind rather than serving the mind. This enactive, 
subjectively body-felt sense, as described by Gendlin (1992), expresses basic meaning from 
a sensory –motor modality and reflects the individual’s life history and current situation. It is 
pre-verbal and preliminary to habitual/pre-conceptual/abstract thinking patterns. During 
TBMA the body is therefore experienced from inside-out, as a lived container of sensations, 
images, thoughts and feelings etc. Joint attention with the facilitator or another participant as 
witness extends the experience as reflections are embodied from the outside-in as well. This 
opportunity to experience the connection between the body and mind whilst doing/being it 
opens up possibilities for new discoveries about the nature, and the meaning of, symptoms 
as located in the bodymind. This is an embodied way of knowing (Panhofer & Payne, 2011), 
contrasting with conceptual knowing. 
Several disciplines cultivate mindfulness, such as yoga, tai chi and qigong, although most of 
the research literature has concentrated on mindfulness developed through mindfulness 
meditation. This self-regulation practice trains attention and awareness to bring mental 
processes under greater voluntary control thereby promoting wellbeing and/or capacities 
such as calmness, clarity and concentration (Walsh & Shapiro, 2006). 
Mindfulness refers to a psychological state of awareness, the practices that promote this 
awareness, a mode of processing information and a character trait and can be defined as a 
moment-to-moment awareness of one's experience without judgment. In this sense, 
mindfulness is a state and not a trait. While it might be promoted by certain practices or 
activities, such as meditation, it is not necessarily synonymous with them. TBMA by using 
kinetic mindful practices engages with the patient’s attention to, and relationship with, their 
bodily symptoms (including pain), for example by exploring the sensory experiences, and 
engaging in action-based inquiry such as examining the nature and purpose of the 
symptoms. This mindful relationship to the body and symptoms helps patients become less 
attached to/identified with their symptoms as well as less reactive to them which diminishes 
their experience of them. 
TBMA coaches patients through exercises involving postures and movement, breath and 
voice, mindfulness and body awareness. Practicing such exploratory exercises regularly in 
the group session (and at home) the patient may regain balance and self-regulation. For 
example, practising focussing on the breath (or the symptoms), then noticing any thoughts, 
images or bodily sensations, followed by re-focussing on the breath, and then reflecting on 
the experience through the creative arts thus nurturing a deep awareness of the body. By 
putting difficult emotions and sensations in a bodily context an indication of a new 
perspective and accompanying meanings can be gained. By holding all these aspects, 
including pain, in direct sensory awareness metaphor/imagery can be generated 
spontaneously. These can be drawn, made out of clay or written about in a personal journal 
often leading to further meaning–making and understanding of the role/nature/purpose of the 
symptoms. Participants are engaged in synchronous, effortful movement together in a circle 
(accompanied by music or not) which has been shown to reduce pain and act as a way to 
increase group cohesion (Tarr, Launay, Cohen, Dunbar, 2015). 
TBMA helps patients to connect cognitive and emotional aspects with reference to their 
sensory/bodily states through the enactment of expressive movement in structured 
exercises. Cognitive activities are inseparable from the body as the brain takes an important 
part in intentionality which involves the process of perceiving and meaning-making (Mills 
2005; Koch, Caldwell, Fuchs, 2013).There is no explicit involvement of any underlying 
psychological conflicts or the interpretation/identification (or subsequent modification of) 
unhelpful thought patterns. Patients learn to notice their bodily signals and explore their 
symptoms often without the need for verbalisation (McWhinney, Epstein, Freeman, 1997), 
thoughts change as a result of the embodied experience.  
TBMA differs significantly from CBT in that it focuses on the physical symptom within an 
experiential inquiry-led learning framework to support patients to live well and cope better in 
a more meaningful way. There is an evidence base for the practice of CBT with some 
specific conditions included in the MUS category e.g. IBS (Mahvi-Shirazi, Fathi-Ashtian, 
Rasoolzade-Tabatabaei, 2012) and fibromyalgia (Woolfolk, Allen, Apter, 2012) but the 
method does not address the body-felt sensory experience of the symptoms, favouring 
solely the mental aspects of depression and /or anxiety. CBT has been researched in large 
trials and is recommended by the National Institute for Clinical and Health Care Excellence 
(NICE) for chronic fatigue and fibromyalgia. However, patients and GPs in the service 
delivery reported in this article spoke about patients’ reluctance to attend anything 
concerned with psychological/mental ill health etc. There is evidence (Sartorius, 2007) to 
suggest that these patients are very wary of the stigma attached to any mental health label. 
It can be concluded that patients with MUS may be less willing to access CBT as they 
believe they have an organic cause rather than give a psychological explanation for their 
symptoms. Allen and Woolfolk (2010) and Gonzalez, Williams, Noel, and Lee (2005) 
demonstrate that this patient population are often resistant to CBT.  
In contrast TBMA is not presented to patients as a psychological therapy. It allows patients 
in the early phase to concentrate on their sensory experience and action patterns involved in 
the symptom. However, there is often a subtle psychological component to the treatment 
discovered by the patient later in the process. Hence patients do not concern themselves 
with the question of stigma in relation to participating in the treatment. Furthermore, TBMA 
addresses a range of symptoms and the symptom itself. It can include a number of different 
symptoms for a number of patients in the same group, together with various accompanying 
aetiology such as alexithymia (Ogrodniczuk, Joyce, Piper, 2013), in which there is confusion 
between emotions and bodily experiences, poor affect regulation and a fearful/insecure 
attachment style (Payne, 2013).  
In TBMA the patient directs her/his attention to inner experiences of self, actively reflecting 
and commenting on bodily sensations as they are raised into awareness. Gradually 
participants become more connected to their embodied, direct experience of self. A more 
positive re-association with the body emerges which has often become dissociated due to 
the patient’s symptom distress. In embracing the wisdom held by the symptom through the 
embodied, enactive dream state the patient enters into a more meaningful dialogue with their 
body. Berg, Sandahl and Bullington (2010) in a study of patient perspectives of the process 
of change in affect-focussed body psychotherapy for generalised anxiety disorder found that 
‘getting in touch with one’s body’ was a key (ibid p151). This in turn gave rise to feelings of 
being in control, for example noticing bodily signals such as muscular tension and being able 
to influence them, and understanding the link between bodily symptoms and emotions. They 
found that patients managed to integrate bodily feelings into their perception of themselves 
resulting in a deeper experience of their lived body. 
 
Structure of the TBMA course 
TBMA groups are short term for up to 12 patients per group; there are three groups per 
programme. Each session is two hours for 12 sessions over ten weeks as in brief therapy 
(Yalom & Leszcz, 2005). Groups are run locally in a suitable community setting. Following 
the groups in phase one, in phase two, and over the following six months contact is 
maintained. For example, a self-addressed letter written by the participant in session 12 is 
sent eight weeks after the end of the group, as is a letter personalised for each participant 
written by their facilitator in month three after the end of the group. Finally, a text/email 
message is sent asking how they are doing, and, if indicated by their response to the 
question, in month nine, a referral to a self-help group is made, otherwise a discharge letter 
is sent to their GP. 
 
Practice-based evidence 
As well as the traditional trials in the evidence-based practice paradigm another form of  
 
evidence is being derived from naturalistic practice settings termed practice-based evidence  
 
(Barkham & Mellor-Clark, 2000).  
 
Practice-based evidence is described by Guy, Thomas, Stephenson, and Loewenthal (2011) 
as complementary to the quantitative, and dominant, randomised control trial-based 
approach to evidence. A United Kingdom Council for Psychotherapy (UKCP) report (Ryan & 
Morgan, 2004, cited in Thomas, Stephenson, & Loewenthal, 2006) suggests that 
practitioners and service users need to be given a voice, acknowledging that they have 
direct knowledge and experience of what works and alternatively what needs to change, and 
how. Practice-based evidence can give them these opportunities. 
P2W employs this practice-based methodology, albeit with smaller numbers. It contrasts with 
evidence-based practice in that it starts with practitioners and patients in real-world settings 
and builds up the evidence rather than as with the traditional top down evidence- based 
medical paradigm. Furthermore, it uses national/common psychological therapies and 
primary care outcome measures such as PHQ9 for measuring depression. Patient 
evaluations of experience and outcomes form an important part of the evidence. Additionally, 
it is using real-world patients electing to participate in the treatment group, rather than 
selected samples willing to participate in research to which they would be blindly allocated to 
either the treatment/treatment as usual without exerting any choice.   
With this practice-based methodology and its evaluation using qualitative and quantitative 
patient feedback and the standardised psychological assessment tools there is an 
opportunity to build an evidence base rooted in routine service delivery. This could 
complement the Cochrane data base2 and together with it, yield a more robust knowledge 
base for the psychological/arts therapies.  
This methodology values expert opinion and acknowledges the need to adjust practice 
according to the needs and preferences of the client and their socio-economic background. 
This complementary paradigm of practice-based evidence also provides a means for 
practitioners to own and generate an evidence base embedded in routine practice. Both 
paradigms are needed as the aim for all practitioners and researchers alike is best practice. 
 
Description of Patients in the Sample: 
Ethnicity: White British – 10; Chinese – 2; Indian – 4 (we do not know if born in Britain from 
this background or if their country of birth). 
Gender mix: The ratio was 5:3 women to men in this small sample of 16 completing the 
whole programme from pre-group assessment to follow up at six months. This reflects the 
literature whereby more women than men somatise.  
Age distribution:  Results from this small sample of 16 suggest that adults of all ages are 
likely to experience MUS.  The biggest age group category was the 50-59 year olds (5/16 
were from this category). The youngest patient was just below 20 years of age and the 
eldest patient was over 80 years old. 
Number of patients in each group: Group 1: four; Group 2: six; Group 3; six.  
Number at completion: 16/19 patients completed the full programme over the two phases to 
the end of the six month follow-up.  
The number of group sessions attended per patient ranged from 8-11.  
Attendance figures: Group 1 had 67%, Group 2 86% and for Group 3 it was 90%. 
The following shows engagement throughout the programme: 
Number entering treatment groups: 19 (one missed the intake meeting but attended the first  
 
two sessions then withdrew, a further one withdrew after first two sessions as too unwell and  
                                                          
2
 An international not-for-profit organisation preparing maintaining and promoting the accessibility of systematic 
reviews of the effects of health care.  
 
one had to have an operation and could not drive so had to discontinue) 
 
Number remaining in treatment: 17 (one remained until session 10 but could not sustain  
thereafter) 
Number completing TBMA group treatment through to follow up: 16 
 
Analysis of questionnaire data  
Insert Table 1 here 
The majority of patients were in the moderate or mild categories for anxiety which is broadly 
consistent with the literature which states that at least two thirds of patients with MUS will 
have anxiety (Grover et al 2014). Higher levels of anxiety show more of an improvement 
than at these lower levels. The majority of patients were women, a finding consistent with the 
literature (Speckens, VanHemert, Bolk, Rooijmans & Hengeveld, 1996). They were of a 
mixed educational background similar to that found by Nimnuan, Hotopf and Wessely 
(2001). Some studies claim that those unemployed, senior women and those from a non-
Western origin experience more MUS (Verhaak, Meijer, Visser & Wolters, 2006). However, 
participants in this project were from a variety of backgrounds and ages.  This is inconsistent 
with some other studies which found, for example, the older age group to be overly 
represented or, in contrast, younger, employed women to be over represented (Nimnuan, 
Hotopf & Wessely, 2001). However, all of these outcomes on the demographics in the 
project are consistent with the previous pilot study. 
Educational background:  Patients came from a range of educational backgrounds. 
Employment status:  5/16 retired, one of which was due to ill health. 7/16 patients were in 
full-time employment; two in part time employment; one was unemployed and one a student. 
Types of symptoms: There were 26 different symptoms for the whole cohort of 16 
 
patients completing the programme to follow up. These included: 
 
 breathlessness 
 headaches 
 chronic pain 
 tiredness 
 insomnia 
 hand pain 
 leg pain 
 chronic fatigue 
 IBS 
 ME 
 palpitations 
 seeing white lights 
 
 pain in the chest 
 backache 
 leg spasm 
 insomnia 
 
Assessment Measures: 
Patients were assessed using standardised measures over the telephone by a clinical 
psychologist on three occasions. Firstly at pre- group, secondly in the final week of the group 
and thirdly at six months follow up. The measures used were: 
PHQ9: This is a client rated tool for depression. It scores each of the nine depression DSM-
IV criteria as "0" (not at all) to "3" (nearly every day).   
Measure Your Medical Outcomes Profile (MYMOP2): This is an individualised outcome 
questionnaire, problem-specific (measures two symptoms chosen by the patient), including 
general wellbeing and impact of symptoms on a chosen activity.  The greater the score, the 
more severe the symptoms will be experienced.  
Generalized Anxiety Disorder 7 (GAD7): This is a brief measure for assessing Generalized 
anxiety disorder on a 7-item self-rating scale. It scores each item as "0" (not at all) to "3" 
(nearly every day) for each item.  Severity of generalised anxiety is graded based on the 
GAD7 score as 0-4 None/5-9 Mild/10-14 Moderate/15-21 severe. 
The Global Assessment of Functioning Scale (GAF): A clinician rating tool used to measure 
overall level of psychological, social and occupational client functioning on a scale ranging 
from 1 to 100. The higher the score, the higher the level of functioning will be. GAF covers 
the range from positive mental health to severe psychopathology. 
P2W Questionnaire: During a telephone interview the assessor collected self-reported 
information on the participant’s age; gender; ethnicity; socio economic group; occupation; 
educational levels; type and number of symptoms; amount of leisure activity; social support; 
work/school attendance; use of medication; attendance at GP/hospital. In addition GP 
referrals contained case histories and medical information. 
 
Insert graph 1 here 
 
Post-group outcomes from the standardised assessments 
The outcomes are also presented as pie charts for greater visual impact and ease of 
interpretation by the general reader.  
Insert pie charts 1-7 here 
 
Insert Table 2 here 
 
Interpretation of outcomes pre to post group 
Improvements are noted in all areas shown from pre- to post group on the Pie Charts 1-7 
and in the Graph I example above. Particularly important are improvements in the scores 
from pre- to post group as shown in the summary Table 2 indicating decreased levels of 
depression, anxiety and symptom severity. There are also improved feelings of overall 
wellbeing, social support, activity levels and global functioning. In addition patients report 
decreased GP visits, medication usage and hospital visits and improvement in their social 
support. 
For the majority of patients’ depression scores were mild or moderate reducing to zero, one 
patient reduced in her score from severe to moderate. The literature (Lowe, Spitzer, 
Williams, Mussell, Schellberg, 2008) states most patients with MUS will have mild to 
moderate depression consequently this sample of patients were more or less in a similar 
category in this regard. 13/16 of patients reported feeling less depressed after attending the 
group intervention. 
Global functioning (psychological, social and occupational) levels also increased for 13/16 of 
patients post group. This is an important finding as functioning is usually impaired as a result 
of MUS causing inactivity, unemployment and a reduced capacity to study. Furthermore, 
social support collected by a questionnaire post group showed improvement for 7/16 of 
patients (Table 1) and this increased for 9/16 patients following attendance post group. This 
may refer to relationships with family and friends improving which could result from the 
higher levels of wellbeing - a positive sign, especially for those with insecure attachments. 
This increased social support (frequently continuing long after the facilitated group 
workshops have ended) may help to account for why patients continue to improve long after 
the groups finish. 
The Overall MYMOP scores improved considerably for 13/16 of patients at post group 
assessment when compared to pre group. This groups the scores of wellbeing, activity, and 
symptom distress, together to make an overall score. It is no surprise that this percentage is 
high when individual percentages for each aspect of MYMOP2 improved. 
Anxiety levels decreased for 11/16 of patients at post group when compared to pre-group 
scores. 3/16 showed no change and 2/16 worsened in their scores for anxiety when 
comparing pre-group with post group. It appears from this result that patients reduce their 
levels of anxiety after the group experience. However, without a control group it is not 
possible to reliably attribute improvements to TBMA as a group experience solely. 
Symptom severity is measured by up to two symptoms per person being reported to be 
better, worse or no change. 17/26 of symptoms were reported as improved post group 
compared with scores at pre-group. This improvement in symptom distress may help 
patients to feel less depressed and anxious and enable them to engage in more activity day-
to-day. Increase in activity may in turn bring about greater social interaction resulting in 
improved feelings of wellbeing. 
For 10/16 of patients there was improvement in general wellbeing as measured by overall 
MYMOP2. In problem specific symptoms almost all patients improved as well as in the 
category of symptom severity. Furthermore, the number of symptoms reported by patients 
pre-group reduced at post-group in over half the sample.  
Activity levels increased for 9/16 (Table 2) of patients with half the sample increasing their 
leisure pursuits (Table 1) probably as a result of the increased functioning levels, which in 
turn could lead to feelings of wellbeing. No patients reduced their activity levels to below 
those at pre-group. For the remainder there was no change in activity levels at post group 
when compared to pre-group levels. 
These results, albeit based on a small sample suggest that at the post-group assessment, 
using standardised psychological tests, patients report feeling the benefits of attending 
TBMA groups.  
Post group to six month follow up outcomes from standardised assessments 
Insert Table 3 here 
Comparison between post group and the six month follow up outcomes as  
demonstrated on the standardised assessments 
Insert pie chart 8 here 
The percentage for depression in Pie Chart 8 in particular worsened for 9/143 patients (it was 
the highest percentage of all categories) as did general wellbeing in MYMOP2 at 6/14 of 
patients (see Pie Chart 13) at follow up when compared to post group data analysis. 
However, as there had been (13/16 patients) reduction in depression at the earlier post 
group stage the worsening of this percentage is not as great as might at first be thought. The 
post group analysis for depression and general wellbeing had improved for all but a very tiny 
percentage of patients when compared to pre-group. Consequently, it could be said that 
there is a reduction in the maintenance of the improvement shown at post-group. The higher 
percentage of increased depression at follow up may be due to the loss of the support of the 
group during the six months post-group to follow up. In contrast there were some 
participants who improved on their previously improved or no change post-group score for 
depression, others remained at the same level of improvement. It would be understandable 
that general wellbeing would decrease if depression increased. However, at follow up 3/14 
patients improved in general wellbeing and 5/14 patients showed no change when 
compared to the post group improvement. Consequently, it could be said that 8/14 patients 
improved or maintained their overall wellbeing. 
It could be speculated that GPs advising that medication for depression be tapered over a  
 
period of time influenced patients’ perception of their levels of depression. Patients on anti- 
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  There are now 14 patients because two patients withdrew in the 6 month post group to follow up 
assessment period 
depressants could want to give them up if they were feeling better, however GP advice to  
 
remain on the medication due to physiological dependency will prevent them from doing   
 
this. 
 
 
Insert pie chart 9 here 
 
 
 
 
Global Assessment of Functioning (GAF) appears to have been about the same for each of 
the improvement and no change categories when comparing post to follow up. 10/14 
patients either improved still further from their post group scores or maintained their 
improvement whilst only 4/14 patients reported feeling worse at follow up than at post group. 
Insert pie chart 10 here 
 
 
 
 
 
 
 
 
8/14 patients showed a large improvement in their overall MYMOP2 score, whilst 5/14 got 
worse only 1/14 showed no change when compared to the improvement shown in the post-
group score. 
Insert pie chart 11 here 
 
 
Anxiety, as measured by GAD7, showed that there was improvement in anxiety (i.e. 
reduction) in 3/14 patients and no change from the post group levels of improvement for 
6/14. Hence approximately 9/14 of patients reported either improvement or maintenance of 
their anxiety levels from post group as measured at follow up. 5/14 patients reported feeling 
more anxious at follow up when compared to post group. On balance most patients 
continued to remain less anxious at the six month follow up when compared to post group 
analysis.  
Insert pie chart 12 here 
 
 
There was a reduction in symptom severity distress 10/27 of symptoms (as in the pilot  
study outcomes) at follow up, with 12/27 reporting no change.  Hence approximately  
22/27 of patients reported either improvement or the same levels of symptom  
severity distress.  
Even though some still experienced their symptoms maybe some could manage them better.  
Others remained the same as at post-group where there had been an improvement in  
coping. 5/27 reported a worsening of their symptoms. Once again the majority of  
patients had maintained their improvement post group or had continued to improve still  
further to the six month follow up stage.  
Insert pie chart 13 here 
 
 
8/14 of patients reported either improvement or maintenance of their general  
 
wellbeing at six months follow-up. A larger number, 6/14 patients, than at post group  
 
reported a decrease in general wellbeing via MYMOP2 scores at follow up as shown Pie  
 
Chart 13.  This is inconsistent with the sustained improvement scores on other instruments.  
 
It is unclear why this is the case; perhaps missing the support of the group, leaving them  
 
feeling more alone with their symptoms.  Nevertheless, 5/14 reported no change and  
 
3/14 improved still further at follow up.  
 
insert pie chart 14 here 
 
 
Levels of activity further increased at follow up in 7/14 patients when compared to post group 
demonstrating some capacity to do more, and feel better for it perhaps. This is contrary to 
the percentage feeling worse for general wellbeing of 6/14 at follow up when compared to 
immediately post group.  
Consequently, despite feeling less well overall in terms of general wellbeing and more 
depressed than at post group patients were still able to continue to maintain and even 
increase their engagement in activity perhaps as result of increased global functioning,  
reduced symptom distress and anxiety levels experienced at follow up. 
 
Trends in the data 
An important trend shown in the six month follow up data analysis is that the improvements 
made at post group are not only sustained at three months post group, as in the previous 
pilot research study, but patients report continued improvement at the six month stage. 
Patients maintained or improved their levels of progress on a number of measures including 
overall global functioning, overall MYMOP, anxiety, symptom distress and activity. In the 
pilot research study previously conducted with a bigger sample, which had been followed up 
randomly in case studies to four years post follow up, patients reported sustained 
improvement at that stage too. 
It is not possible to know precisely why improvement continues so long after post group but it 
could be speculated that this may be linked to their embodied change in perception towards 
their body (and symptoms), the action plan to change the way they manage their life (and 
symptoms) which is tailor-made by each patient, as well as because of the group experience 
and the individual contact experienced in phase one and two. From the Participant 
Experience Form (PEF) patients appear to have enjoyed the group experience and hence 
attendance at all the groups was excellent.  
 
Discussion 
This is a very minor piece of practice-based evidence and as the numbers are still very small 
any interpretation must be undertaken with extreme caution. Interestingly, some patients 
develop new symptoms. Whilst this was not demonstrated previously in the earlier pilot study 
(Payne & Stott 2010), it has been reported in the literature. 
Patients appear to have found the programme acceptable and were committed to attend the 
groups. From the PEF, they said that they had benefited from the group experience having 
no hesitation in recommending it to friends and family. 
Therefore there are some hints from this treatment intervention data analysis about how 
Symptoms Groups can mobilise patients towards self-management. There is no alternative 
treatment available and appealing. This is because patients do not see the more widely 
offered CBT as relevant as most have a physical explanation rather than a psychological 
one for their symptoms. In addition the stigma attached to psychological interventions means 
that they feel unable to access such therapy.  
These patients are extremely high utilizers of health resources and consequently, supporting 
these patients is essential not only for the patients but for saving NHS resources and 
increasing GP capacity. The frustration experienced by both patients and GPs as a result of 
the lack of treatment options to support these high health utilizers can be resolved through 
delivery of programmes via The MUS Clinic. 
 
Summary 
First indications from the delivery of TBMA in primary care suggest that it can benefit 
patients with MUS and the health service by encouraging coping strategies which promote 
patient self-management thereby reducing the demand for and cost of services. In addition, 
it is acceptable to patients and provides more patient and GP choice of treatment for MUS. 
Furthermore, we know from patient self-reporting that the courses helped GP practices to 
conserve costs by reducing consultation time, and increasing capacity crucial in these times 
of low GP recruitment in the NHS in England. If the apparent positive trends indicated in this 
very small sample were maintained after the sample is scaled up, with addition of a control, 
the findings would be of great interest. This is therefore a subject for further research.  
P2W intends to continue to improve the lives of patients with MUS in Hertfordshire, England 
and are actively pursuing similar service delivery elsewhere through the training of 
facilitators qualified in the fields of dance movement psychotherapy, body psychotherapy 
and appropriately qualified counsellors/psychotherapists/health professionals. P2W has 
trained 30 group facilitators in TBMA so far with a view to them facilitating groups privately 
under licence and in the NHS and/or in the private health care sector.4  
 
                                                          
4 Training courses, dates and information can be found at www.pathways2wellbeing.com 
Or email info@pathways2wellbeing.com  
twitter @p2w_ltd 
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Clinical outcomes from The BodyMind Approach™  
for the treatment of patients with medically unexplained symptoms  
in an English primary care setting: Practice-based evidence 
Table 1: To show pre to post group analysis of questionnaire  
TEST Improved Worsened No change 
 
Leisure 
 
9/16 (56%) 
 
3/16 (19%) 
 
4/16 (25%) 
 
Support 
 
 
Absence from Work  
 
7/16 (44%) 
 
 
0/16 (0%) 
 
 
9/16 (56%)) 
 
 
(Group 3 only) 
 
GP visits 
(Groups 2 & 3 only 
Missing data: 1 person) 
 
 
1/6 (17%) 
  
4/11(36%) 
0/6 (0%) 
 
4/11 (36%) 
5/6 (83%) 
 
3/11 (28%) 
Hospital visits 
(Groups 2 & 3 only) 
7/12 (58%) 1/12 (8%) 4/12(33%) 
  
 
                
Medication 3/16 (19%) 1/16 (6%) 12/16 (75%) 
 
      
   
Number Symptoms 12/16 (75%) 0/16 4/16 (25%) 
 
 
   
Employment status   0/16 (0%)   0/16 (0%) 16/16 (100%) 
NB one person changed to a different type of medication and was entered under no change 
 
 
 
 
 
 
 
 
Figure
Table 2: To show patient changes in function of pre to post group 
TEST Improved Worsened No change 
 
Depression PHQ9 
 
 
13/16 (81%) 
 
1/16 (6%) 
 
2/16 (13%) 
Global Functioning  GAF 
 
 
Overall  MYMOP2  
13/16 (81%) 
 
 
13/16 (81%) 
1/16 (6%) 
 
 
1/16 (6%) 
2/16 (13%) 
 
 
2/16 (13%) 
 
 
Anxiety  GAD7 
 
 
11/16 (69%)        
 
2/16 (13%) 
 
3/16 (19%) 
    
Symptoms MYMOP2 17/26 (65%) 
 
2/26 (8%)               7/26 (27%) 
    
General Wellbeing MYMOP2 
      
10/16 (63%) 2/16 (13%) 4/16 (25%) 
    
Activity MYMOP2 
 
9/16 (56%) 0/16 (0%) 7/16 (44%) 
    
 
Table 3: To show patient changes in function post group to six months follow up  
TEST Improved Worsened No change 
 
Depression PHQ9 
 
 
3/14 (21%) 
 
9/14 (64%) 
 
2/14 (14%) 
Global Functioning  GAF 
 
 
Overall  MYMOP2  
4/14 (29%) 
 
 
8/14 (57%) 
4/14 (29%) 
 
 
5/14 (36%) 
6/14 (43%) 
 
 
1/14 (7%) 
 
 
Anxiety  GAD7 
 
 
3/14 (21%)        
 
5/14 (36%) 
 
6/14 (43%) 
    
Symptoms MYMOP2 10/27 (37%) 
 
5/27 (19%)               12/27 (44%) 
    
General Wellbeing MYMOP2 
      
3/14 (21%) 6/14 (43%) 5/14 (36%) 
    
Activity MYMOP2 
 
7/14 (50%) 3/14 (21%) 4/14 (29%) 
NB percentages have been rounded up; symptoms category reflects numbers of symptoms (up to 2 
per patient) 
 
Graph 1: Example of percentage improvement in social support, medication, GP & hospital visits 
 
Pie Chart 1: Patients reporting reduced feelings of depression  
81.25% of patients reported a reduction in depression 
 
Pie Chart 2: Percentage of patients reporting improved Global Functioning 
81.25% of patients report and improvement in global functioning 
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Pie Chart 3: Percentage of patients reporting increased overall score for MYMOP including activity, 
symptom severity and wellbeing 
81.25% of patients report improvement in overall scores 
 
Pie Chart 4: percentage of patients reporting reduced anxiety levels 
68.75% of patients reported a reduction in anxiety 
 
                   Pie Chart 5: Percentage of patients reporting Symptom Severity 
65.3% of patients reported an improvement in symptoms 
 
Pie Chart 6: Percentage of patients reporting increased general wellbeing 
62.5% of patients report improvement in their feeling of general wellbeing 
Pie Chart 1: Key: blue=62.5%; green 25%; red 12.5% 
 
 
 
 
 
mymop overall 
81.25% increased 
6.25% decreased 
12.5% no change 
anxiety 
68.75% reduced 
12.5% increased 
18.75% no change 
symptom severity 
65.3%decrease 
7.6%increase 
26.9%no change 
 general wellbeing 
increased wellbeing 
decreased wellbeing 
no change 
Pie Chart 7: Percentage of patients reporting improved activity  
56.25% of patients report improved activity 
 
 
 
 
 
Pie Chart 8: Percentage of patients reporting depression  
 
Pie Chart 9: Percentage of patients reporting global functioning 
 
Pie Chart 10: Percentage of patients reporting overall score for MYMOP2  
 
 activity 
56.25% improved activity 
0% decreased activity 0% 
43.75%no change 
depression 
reduced 
increased 
no change 
global functioning 
improved 
worsened 
no change 
mymop overall  
improved 
worsened 
no change 
 Pie Chart 11: Percentage of patients reporting anxiety 
 
 
Pie Chart 12: Percentage of patients reporting symptom severity 
 
 
Pie Chart 13: Percentage of patients reporting general wellbeing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anxiety 
Reduced 
Increased 
No Change 
symptom severity 
reduced 
increased 
no change 
 MYMOP2 general wellbeing  
improved 
worsened 
no change 
Pie Chart 14: Percentage of patients reporting activity levels 
 
 
MYMOP2 activity 
improved 
worsened 
no change 
